CorVel (NASDAQ:CRVL) Posts Earnings Results

CorVel (NASDAQ:CRVL) issued its earnings results on Tuesday. The business services provider reported $0.46 EPS for the quarter, Zacks reports. CorVel had a net margin of 9.64% and a return on equity of 31.73%.

CorVel Stock Up 0.1 %

Shares of NASDAQ CRVL opened at $115.97 on Tuesday. CorVel has a 12-month low of $76.20 and a 12-month high of $127.24. The firm’s 50-day simple moving average is $123.76 and its 200 day simple moving average is $111.79. The company has a market cap of $5.91 billion, a price-to-earnings ratio of 73.87 and a beta of 1.16.

Insider Activity

In other news, EVP Mark E. Bertels sold 1,050 shares of the business’s stock in a transaction on Thursday, December 5th. The shares were sold at an average price of $119.12, for a total value of $125,072.50. Following the completion of the transaction, the executive vice president now owns 2,580 shares of the company’s stock, valued at $307,321. The trade was a 28.93 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 47.57% of the company’s stock.

Analysts Set New Price Targets

Separately, StockNews.com lowered shares of CorVel from a “buy” rating to a “hold” rating in a research report on Friday, January 3rd.

About CorVel

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.